Get the Stockscreener App
1.42
2.90%
0.04
Bluejay Diagnostics Inc stock is traded at $1.42, with a volume of 8,748.
It is up +2.90% in the last 24 hours and down -38.53% over the past month.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.
See More
Previous Close:
$1.38
Open:
$1.4006
24h Volume:
8,748
Relative Volume:
0.00
Market Cap:
$2.58M
Revenue:
-
Net Income/Loss:
$-8.59M
P/E Ratio:
-0.00103
EPS:
-1373
Net Cash Flow:
$-9.25M
1W Performance:
+0.00%
1M Performance:
-38.53%
6M Performance:
-21.55%
1Y Performance:
-60.77%
1-Day Range:
$1.40
$1.42
1-Week Range:
$1.235
$1.45
52-Week Range:
$1.235
$10.20
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics Inc
Sector
Industry
Phone
(978) 631-0152
Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.42 | 2.50M | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
128.81 | 222.66B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
101.67 | 150.26B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
372.08 | 143.44B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.58 | 135.12B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.97 | 50.38B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bluejay Diagnostics Inc Stock (BJDX) Latest News
Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Bluejay Diagnostics Inc Stock Analysis and ForecastFlag and Pennant Patterns & Exceptional Capital Investment - earlytimes.in
Why Bluejay Diagnostics Inc. stock could outperform in 20252025 Volatility Report & Low Drawdown Trading Techniques - newser.com
How Bluejay Diagnostics Inc. stock reacts to oil pricesQuarterly Profit Report & High Conviction Buy Zone Alerts - newser.com
Why Bluejay Diagnostics Inc. stock could benefit from AI revolution2025 Price Targets & Low Risk Entry Point Tips - newser.com
How geopolitical tensions affect Bluejay Diagnostics Inc. stockJuly 2025 Macro Moves & Low Risk Entry Point Guides - newser.com
Statistical indicators supporting Bluejay Diagnostics Inc.’s strengthEarnings Beat & High Conviction Buy Zone Picks - newser.com
Using data filters to optimize entry into Bluejay Diagnostics Inc.Earnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Tick level data insight on Bluejay Diagnostics Inc. volatilityJuly 2025 Weekly Recap & Weekly Momentum Picks - newser.com
Custom watchlist performance reports with Bluejay Diagnostics Inc.Analyst Downgrade & Weekly High Momentum Picks - newser.com
Risk adjusted return profile for Bluejay Diagnostics Inc. analyzed2025 EndofYear Setup & Daily Risk Controlled Trade Plans - newser.com
What Wall Street predicts for Bluejay Diagnostics Inc. stock priceInsider Buying & Fast Gain Stock Trading Tips - newser.com
Analyzing drawdowns of Bluejay Diagnostics Inc. with statistical toolsPortfolio Update Summary & AI Based Buy and Sell Signals - newser.com
Bluejay Diagnostics, Inc. (BJDX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Why Bluejay Diagnostics Inc. stock remains on watchlists2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
Is Bluejay Diagnostics Inc. stock a safe buy before earningsJobs Report & Daily Entry Point Alerts - newser.com
Bluejay Diagnostics Corporate Update, Advancing Clinical Milestones and Strategic Partnerships - MarketScreener
Bluejay Diagnostics reports progress on sepsis test clinical trial By Investing.com - Investing.com Nigeria
Will Bluejay Diagnostics Inc. stock maintain momentum in 2025Earnings Trend Report & High Conviction Investment Ideas - newser.com
Bluejay Diagnostics Reports Q3 Results and Updates - TipRanks
Bluejay Diagnostics, Inc. Provides Q3 2025 Financial and Corporate Update - TradingView
[8-K] Bluejay Diagnostics, Inc. Reports Material Event | BJDX SEC FilingForm 8-K - Stock Titan
Bluejay Diagnostics reports progress on sepsis test clinical trial - Investing.com
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
2.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):